SGLT 2 Inhibitors: A New Therapeutic Target And Its Role In Current Clinical Practice

Journal Title: BMH Medical Journal - Year 2015, Vol 2, Issue 4

Abstract

Diabetes, one of the major life style diseases, is associated with high morbidity and mortality owing to its microvascular and macrovascular complications. The chance of development of various complications can be effectively prevented by tight glycemic control. We have various groups of drugs like Biguanides, Sulfonyl ureas, Glitazones, Alpha-glucosidase inhibitors, Incretin based therapy, Insulin and Insulin analogues in the armamentarium to treat diabetes. But still, the number of patients attaining glycemic targets are relatively low and various adverse effect limit the use of some of these drugs, especially in special groups. Hence there is ongoing research to develop newer and newer drugs which provide sustained blood glucose reduction with minimal adverse effects. SGLT-2 inhibitors are a new group of drugs recently approved by FDA to treat Diabetes. In this review we discuss about mechanism of action, various adverse effects and the clinical role of various SGLT-2 Inhibitors.

Authors and Affiliations

PV Shiji, AV Raveendran

Keywords

Related Articles

Persistent Trigeminal Artery

Trigeminal artery is the commonest of the four primitive anastomoses between the carotid and vertebrobasilar system that may rarely persist in adults, with an angiographic incidence of 0.1 - 0.6%. We present the CT and M...

Diagnosis of Pentalogy of Cantrell in First Trimester Ultrasound

Reporting first trimester diagnosis of a case of Pentalogy of Cantrell by Ultrasonogram. Routine antenatal ultrasound at 12 weeks and 4 days demonstrated a single live intrauterine fetus with anterior wall abdominal wal...

A Case of Hybrid Carotid Revascularization

Cerebral infarction attributed to extracranial carotid and vertebral artery disease is defined as clinical stroke with evidence of infarction on brain imaging associated with >50% stenosis or occlusion of an extracranial...

Late Postoperative Spondylodiscitis Due To Concurrent Infection Of Klebsiella Pneumonia And Mycobacterium Tuberculosis - A Case Report

The present paper reports the case of a 59 year old male, having diabetes mellitus, hypertension and chronic liver disease, with postoperative infection in an instrumented posterior spinal fusion caused by concurrent inf...

Tuberculous Abscess At Diphtheria, Pertusis And Tetanus (DPT) Vaccination Injection Site

Localized abscess at the same site of bacillus Calmette-Guerin (BCG) vaccine is a known complication. However occurrence of such abscess at other sites is uncommon. We report a case of a small child who developed swellin...

Download PDF file
  • EP ID EP324097
  • DOI -
  • Views 108
  • Downloads 0

How To Cite

PV Shiji, AV Raveendran (2015). SGLT 2 Inhibitors: A New Therapeutic Target And Its Role In Current Clinical Practice. BMH Medical Journal, 2(4), 97-101. https://europub.co.uk/articles/-A-324097